Roxarsone is going off the market, at least temporarily, after being used for more than 60 years to control coccidia in poutlry as a result of an agreement between the U.S. Food & Drug Administration (FDA) and Alpharma LLC, a subsidiary of pharmaceutical giant Pfizer.
Continue reading »
